# Early Versus Delayed Norepinephrine Initiation in Septic Shock: A Systematic Review and Meta-Analysis of Randomized and Observational Studies

## TL;DR

This study reviews whether starting norepinephrine early in septic shock improves survival, finding mixed evidence from different types of studies.

## Contribution

The paper provides a systematic review and meta-analysis comparing early versus delayed norepinephrine initiation in septic shock.

## Key findings

- Early norepinephrine was linked to a modest but non-significant mortality reduction in randomized trials.
- Observational studies showed a significant survival benefit with early norepinephrine initiation.
- Heterogeneity in results suggests variability in study design and patient populations.

## Abstract

Septic shock remains a major cause of illness and death worldwide despite improvements in critical care, and the optimal timing for starting norepinephrine continues to generate debate.

This review assessed whether administering norepinephrine within the first hour of recognizing shock or upon ICU admission provides meaningful advantages compared with delayed initiation.

A broad search of major databases from 2010 to May 2025 identified randomized trials and observational studies examining early versus later administration. Twenty-eight studies met the inclusion criteria, and nine were eligible for meta-analysis.

The pooled results showed that early norepinephrine was associated with a modest but statistically non-significant reduction in mortality (RR 0.90; 95% CI 0.76-1.06; p = 0.18). Observational studies, however, demonstrated a clearer survival benefit, with early initiation linked to a significant decrease in deaths (RR 0.75; 95% CI 0.60-0.94). Moderate heterogeneity (I² = 65.6%) likely reflected variation in study design, patient severity, and differences in defining early treatment.

Overall, the evidence suggests that early norepinephrine may help stabilize hemodynamics more quickly and could improve clinical outcomes, though current randomized data remain limited.

Further high-quality research is needed to better define the magnitude of benefit and guide consistent practice.